首页> 外文OA文献 >Nucleic Acid Vaccination with Schistosoma mansoni Antioxidant Enzyme Cytosolic Superoxide Dismutase and the Structural Protein Filamin Confers Protection against the Adult Worm Stage
【2h】

Nucleic Acid Vaccination with Schistosoma mansoni Antioxidant Enzyme Cytosolic Superoxide Dismutase and the Structural Protein Filamin Confers Protection against the Adult Worm Stage

机译:曼氏血吸虫抗氧化剂酶的细胞质超氧化物歧化酶和结构蛋白菲拉明的核酸疫苗赋予了针对成虫阶段的保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Schistosomiasis remains a worldwide endemic cause of chronic and debilitating illness. There are two paradigms that exist in schistosome immunology. The first is that the schistosomule stages are the most susceptible to immune killing, and the second is that the adult stage, through evolution of defense mechanisms, can survive in the hostile host environment. One mechanism that seems to aid the adult worm in evading immune killing is the expression of antioxidant enzymes to neutralize the effects of reactive oxygen and nitrogen species. Here, we challenge one paradigm by targeting adult Schistosoma mansoni worms for immune elimination in an experimental mouse model using two S. mansoni antioxidants, cytosolic superoxide dismutase (SmCT-SOD) and glutathione peroxidase (SmGPX), and a partial coding sequence for a structural protein, filamin, as DNA vaccine candidates. DNA vaccination with SmCT-SOD induced a mean of 39% protection, filamin induced a mean of 50% protection, and SmGPX induced no protection compared to controls following challenge with adult worms by surgical transfer. B- and T-cell responses were analyzed in an attempt to define the protective immune mechanism(s) involved in adult worm killing. SmCT-SOD-immunized mice presented with a T1 response, and filamin-immunized mice showed a mixed T1-T2 response. We provide evidence for natural boosting after vaccination. Our results demonstrate that adult worms can be targeted for immune elimination through vaccination. This represents an advance in schistosome vaccinology and allows for the development of a therapeutic as well as a prophylactic vaccine.
机译:血吸虫病仍然是世界范围内慢性病和衰弱性疾病的流行病。血吸虫免疫学存在两种范式。首先是血吸虫阶段最容易受到免疫杀伤,其次是成年阶段,通过防御机制的演变,可以在敌对宿主环境中生存。似乎有助于成虫蠕虫逃避免疫杀伤的一种机制是抗氧化剂酶的表达,以中和活性氧和氮物种的影响。在这里,我们通过使用两种曼氏曼森尼抗氧化剂,胞质超氧化物歧化酶(SmCT-SOD)和谷胱甘肽过氧化物酶(SmGPX)以及一种结构的部分编码序列,针对成年曼氏血吸虫蠕虫针对小鼠免疫模型的免疫消除挑战一种范例蛋白质,纤维蛋白,作为DNA疫苗的候选物。与成虫通过手术转移攻击相比,用SmCT-SOD进行的DNA疫苗接种平均诱导了39%的保护,丝质蛋白平均诱导了50%的保护,而SmGPX没有诱导任何保护。分析了B细胞和T细胞反应,以试图确定杀灭成年蠕虫所涉及的保护性免疫机制。 SmCT-SOD免疫小鼠表现出T1应答,而丝素蛋白免疫小鼠表现出混合的T1-T2应答。我们提供疫苗接种后自然加强的证据。我们的结果表明,成年蠕虫可以通过疫苗接种来消除免疫。这代表了血吸虫病疫苗学的进步,并允许开发治疗性和预防性疫苗。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号